APA (7th ed.) Citation

N, M., JJ, I., & JJ, D. (2026). Engineering TCR-directed T-cells for the treatment of multiple myeloma. Frontiers in immunology, 17, 1755096. https://doi.org/10.3389/fimmu.2026.1755096

Chicago Style (17th ed.) Citation

N, Mubin, Ignatz-Hoover JJ, and Driscoll JJ. "Engineering TCR-directed T-cells for the Treatment of Multiple Myeloma." Frontiers in Immunology 17 (2026): 1755096. https://doi.org/10.3389/fimmu.2026.1755096.

MLA (9th ed.) Citation

N, Mubin, et al. "Engineering TCR-directed T-cells for the Treatment of Multiple Myeloma." Frontiers in Immunology, vol. 17, 2026, p. 1755096, https://doi.org/10.3389/fimmu.2026.1755096.